AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, while Organon overstepped the mark in its promotion of contraceptive Nexplanon ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results